Injections are favored for severe deficiency, malabsorption (e.g., postGI surgery, chronic diarrhea), very low B12 levels with neurologic signs, poor adherence, or when rapid repletion is needed
For instance, dual-receptor agents like tirzepatide, as well as higher doses, are linked to greater weight loss
The combination of pharmacological and activity-based energy expenditure increases can accelerate results
Do not increase the dose on your own
The BioStation staff also offers a weight-loss program built around semaglutide, a compound approved by the Food and Drug Administration (FDA) in 2021 to help people with chronic weight-management conditions or those who are overweight with one weight-related condition